Full Text
Is Drug Innovation Still Rewarded in the Top 5 European Pharmaceutial Markets?

Abstract

Authors

F. Reinaud G. Ando

Back to Volume 16, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×